全文获取类型
收费全文 | 4477篇 |
免费 | 270篇 |
国内免费 | 85篇 |
专业分类
耳鼻咽喉 | 88篇 |
儿科学 | 141篇 |
妇产科学 | 38篇 |
基础医学 | 574篇 |
口腔科学 | 59篇 |
临床医学 | 534篇 |
内科学 | 724篇 |
皮肤病学 | 108篇 |
神经病学 | 611篇 |
特种医学 | 392篇 |
外科学 | 650篇 |
综合类 | 52篇 |
一般理论 | 2篇 |
预防医学 | 187篇 |
眼科学 | 170篇 |
药学 | 241篇 |
肿瘤学 | 261篇 |
出版年
2021年 | 54篇 |
2020年 | 26篇 |
2019年 | 51篇 |
2018年 | 66篇 |
2017年 | 55篇 |
2016年 | 72篇 |
2015年 | 89篇 |
2014年 | 98篇 |
2013年 | 112篇 |
2012年 | 179篇 |
2011年 | 175篇 |
2010年 | 142篇 |
2009年 | 120篇 |
2008年 | 197篇 |
2007年 | 214篇 |
2006年 | 170篇 |
2005年 | 192篇 |
2004年 | 174篇 |
2003年 | 157篇 |
2002年 | 154篇 |
2001年 | 134篇 |
2000年 | 139篇 |
1999年 | 129篇 |
1998年 | 138篇 |
1997年 | 133篇 |
1996年 | 139篇 |
1995年 | 106篇 |
1994年 | 116篇 |
1993年 | 94篇 |
1992年 | 66篇 |
1991年 | 84篇 |
1990年 | 64篇 |
1989年 | 81篇 |
1988年 | 92篇 |
1987年 | 67篇 |
1986年 | 81篇 |
1985年 | 76篇 |
1984年 | 31篇 |
1983年 | 43篇 |
1982年 | 38篇 |
1981年 | 31篇 |
1980年 | 27篇 |
1979年 | 22篇 |
1978年 | 22篇 |
1977年 | 34篇 |
1976年 | 21篇 |
1975年 | 17篇 |
1970年 | 16篇 |
1914年 | 16篇 |
1913年 | 25篇 |
排序方式: 共有4832条查询结果,搜索用时 15 毫秒
1.
J.L. Bernat A.M. D'Alessandro F.K. Port T.P. Bleck S.O. Heard J. Medina S.H. Rosenbaum M.A. DeVita R.S. Gaston R.M. Merion M.L. Barr W.H. Marks H. Nathan K. O'Connor D.L. Rudow A.B. Leichtman P. Schwab N.L. Ascher R.A. Metzger V. Mc Bride W. Graham D. Wagner J. Warren F.L. Delmonico 《American journal of transplantation》2006,6(2):281-291
A national conference on organ donation after cardiac death (DCD) was convened to expand the practice of DCD in the continuum of quality end-of-life care. This national conference affirmed the ethical propriety of DCD as not violating the dead donor rule. Further, by new developments not previously reported, the conference resolved controversy regarding the period of circulatory cessation that determines death and allows administration of pre-recovery pharmacologic agents, it established conditions of DCD eligibility, it presented current data regarding the successful transplantation of organs from DCD, it proposed a new framework of data reporting regarding ischemic events, it made specific recommendations to agencies and organizations to remove barriers to DCD, it brought guidance regarding organ allocation and the process of informed consent and it set an action plan to address media issues. When a consensual decision is made to withdraw life support by the attending physician and patient or by the attending physician and a family member or surrogate (particularly in an intensive care unit), a routine opportunity for DCD should be available to honor the deceased donor's wishes in every donor service area (DSA) of the United States. 相似文献
2.
3.
4.
5.
6.
7.
8.
Dr. R. Schwab C. Schneider K. Junge M. Stumpf H. P. Becker V. Schumpelick 《Der Chirurg》2004,75(2):200-205
The solitary fibrous tumor (SFT) is a very rare and usually benign neoplasm. This tumor is mostly located in the thoracic cavity, but it has also been reported in numerous sites including liver, skin, and meninges. Due to its rarity diagnosis is often difficult. Accordingly, histopathological differentiation is of major importance. Solitary fibrous tumors consistently express CD 34 and react negatively to epithelial markers. This absence of expression of epithelial markers, especially cytokeratin, is also useful to distinguish these rare entities from sarcomatous mesotheliomas. The treatment of choice for solitary fibrous tumors is extensive surgical resection. Up to now there is no evidence that radiation and chemotherapy are effective. The local recurrence or onset of metastases depends on histologic parameters. In cases of benign classification (60-80%), the recurrence rate was only 2% after surgical excision. One-half of the patients with malignant tumors can be cured; the rest develop recurrences and metastases more often. Especially in those cases, emphasis should be placed on continual follow-up examination. We report two cases of a 65- and a 75-year-old male patient with huge intrathoracic solitary fibrous subpleural tumors, discovered incidentally on routine chest X-ray. 相似文献
9.
10.